Benitec Biopharma (BNTC) Return on Capital Employed [ROCE] (2020 - 2026)
Benitec Biopharma's Return on Capital Employed [ROCE] came in at -37.71% for FY2026 (year ended Jun 30, 2026), up 18.66 percentage points from -56.36% in FY2025.
Powered by 
Analysis
Benitec Biopharma (BNTC) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
Going back to FY2020, Benitec Biopharma's Return on Capital Employed [ROCE] data covers 7 fiscal years.
- Return on Capital Employed [ROCE] has increased in each of the last three fiscal years, with a five-year change of +52.25 percentage points (FY2021 to FY2026).
- The FY2026 figure represents the highest annual Return on Capital Employed [ROCE] in data going back to FY2020.
- Per Business Quant, earlier fiscal years put Return on Capital Employed [ROCE] at -56.36% in FY2025 (+39.69 pp), -96.06% in FY2024 (+1442.11 pp), -1538.17% in FY2023 (-1377.96 pp) and -160.21% in FY2022 (-70.26 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Benitec Biopharma | 432.06 Mn | -216.04 Mn | - | -28.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.52% |
| Mar 31, 2026 | -25.11% |
| Dec 31, 2025 | -34.40% |
| Sep 30, 2025 | -47.79% |
| Jun 30, 2025 | -41.52% |
| Mar 31, 2025 | -44.03% |
| Dec 31, 2024 | -37.11% |
| Sep 30, 2024 | -40.06% |
| Jun 30, 2024 | -78.42% |
| Mar 31, 2024 | -145.82% |
| Dec 31, 2023 | -117.53% |
| Sep 30, 2023 | -181.52% |
| Jun 30, 2023 | -807.15% |
| Mar 31, 2023 | -278.88% |
| Dec 31, 2022 | -146.86% |
| Sep 30, 2022 | -194.99% |
| Jun 30, 2022 | -325.44% |
| Mar 31, 2022 | -167.54% |
| Dec 31, 2021 | -128.71% |
| Sep 30, 2021 | -87.35% |
API Access
Benitec Biopharma Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BNTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "BNTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BNTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();